Accreditation

Upon completion of these educational activities, participants will be able to:

Module 1

  • Accurately diagnose and assess the severity of COPD
  • State the goals of COPD management
  • Describe maintenance pharmacotherapy for COPD patients
  • Incorporate smoking cessation, vaccination, and pulmonary rehabilitation into COPD treatment plans

Module 2

  • Explain why spirometry is done in suspected COPD patients
  • Discuss correct technique when performing spirometry
  • Identify common patterns for normal, as well as obstructive and restrictive lung diseases
  • Identify the uses of spirometry and pulmonary function tests in COPD care

Module 3

  • Learn why physicians are best suited to address tobacco use with patients.
  • Understand the clinician’s role and importance of non-pharmacologic intervention in the management of your patients with COPD
  • Identify the need for oxygen therapy in your COPD patients
  • Understand the classes of inhaled medications used for COPD maintenance

Module 4

  • Understand the advantages of inhaled drug delivery
  • Examine the differences of the various methods of inhaled drug delivery
  • Identify the challenge of patient non-adherence
  • Learn how to adopt Shared Decision Making into your clinical work

COPD101: Basic Diagnosis and Management
CME Credit: 1.0   CNE Credit: 1.2

COPD Diagnosis – By The Numbers
CME Credit: 1.0   CNE Credit: 1.2

Optimizing COPD Management
CME Credit: 1.0   CNE Credit: 1.2

COPD Patient-Centered Care – Adherence With Therapy
CME Credit: 1.0   CNE Credit: 1.2

Target Audience

The target audience for these activities include Primary Care Physicians, Advanced Practice Nurses, Physician Assistants, Registered Nurses and Medical Assistants who are involved in the management of COPD.

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Physicians – National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™ for each program. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses –  Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 1.2 contact hours.

PAs may claim a maximum of 4.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or recognized state medical society.

The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with AANPCB for further guidelines.

Program Support

This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP as a supplement to NIH grant 1R01HL136682-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of AstraZeneca, the NHLBI or the NIH.

Requirements for Successful Completion

In order to receive credit, participants must complete the pre-test, view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test with a passing score of ≥ 75%, and evaluation form.

Faculty Disclosure / Conflict of Interest Policy

Faculty Presenters

Bruce Bender, PhD

  • Professor of Pediatrics and Psychiatry, Head, Division of Pediatric Behavioral Health, Co-Director, Center for Health Promotion, National Jewish Health, Denver, CO
  • Disclosures: Consultant for KAC Health and an Advisory Board Member for GlaxoSmithKline and Propeller Health.

Deborah Fending RN, BSN, AE-C

  • Staff Development Nurse, Center for Health Promotion, Department of Nursing, National Jewish Health, Denver, CO
  • Disclosures: Advisory Board Member for Boehringer Ingelheim.

Barry Make, MD

  • Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO
  • Disclosures: Advisory Board Member for AstraZeneca, Boehringer Ingelheim, Circassia, GlaxoSmithKline, Novartis, Phillips, Science 24/7, Shire, Spiration, Sunovion, Theravance, Verona. He also has relationships National Heart, Lung and Blood Institute, Pearl and Third Pole.

Barbara P. Yawn, MD, MSc, MSPH

  • Adjunct Professor, Family and Community Health, University of Minnesota, Chief Science Officer, COPD Foundation
  • Disclosures: Advisory Board Member for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis.

  Betty Carter

  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Susan Bollig

  • Disclosures: No financial interests/relationships or affiliations in relations to this activity.

Mark McCormick

  • Disclosures: No financial interests/relationships or affiliations in relations to this activity.

Ted Koppel

  • Disclosures: No financial interests/relationships or affiliations in relations to this activity.

Grace Ann Dorney Koppel

  • Disclosures: No financial interests/relationships or affiliations in relations to this activity.
Faculty Reviewers

Harold Nelson, MD

  • Professor of Medicine, National Jewish Health, Denver, CO
  • Disclosures: Consultant and Speaker for ALK and on a Data Safety Monitoring Board for Pearl Therapeutics.

Ann Mullen, RN, CNS, MSB, AE-C, CD, TTS

  • Patient Education Coordinator & Clinical Nurse Specialist,Department of Nursing, National Jewish Health, Denver, CO
  • Disclosures: Has no financial interests/relationships or affiliations in relation to this activity.

Allidah Hicks, RN, MS, AE-C

  • Staff Development Nurse, Department of Nursing, National Jewish Health, Denver, CO
  • Disclosures: Has no financial interests/relationships or affiliations in relation to this activity.

Tristan Huie, MD

  • Pulmonologist, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO
  • Disclosures: Investigator for Boehringer Ingelheim and the Pulmonary Fibrosis Foundation.
Program Planners

Andrea Harshman, MHA, CHCP, CMP-HC

  • Director, Office of Professional Education, National Jewish Health, Denver, CO
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Stephanie Corder, ND, RN, CHCP

  • Accreditation and Programs Manager, Office of Professional Education, National Jewish Health, Denver, CO
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Matthew Stern, MS

  • Medical Education Project Specialist, Office of Professional Education, National Jewish Health, Denver, CO
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Lauren Rieck

  • Medical Education Project Specialist, Office of Professional Education, National Jewish Health, Denver, CO
  • Disclosures:  No financial interests/relationships or affiliations in relation to this activity.

Randall Brown, MD

  • Director of Asthma Programs, Center for Managing Chronic Disease, University of Michigan School of Public Health, Ann Harbor, MI
  • Disclosures: Speaker for AstraZeneca, Circassia, Integrity CE, One City Health, Sunovion, and Teva. He is a consultant for One City Health and serves on the advisory boards for AstraZeneca, One City Health, and Sanofi/Genzyme. He also has a relationship with the Allergy and Asthma Network.

Lyle Fanagan, MD

  • Professor, Department of Family Medicine, Oregon Health and Science University, Portland, OR
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Daniel Howard, MD

  • Physician and Medical Director, Respiratory Health Service Line, Atrium Health, Charlotte, NC
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Lyndee Knox, MD

  • Chief Executive Officer, L.A. Net Community Health Resource Network, Los Angeles, CA
  • Disclosures: No financial interests/relationships or affiliations in relation to this activity.

Elisha Malanga

  • Chief Research Officer, COPD Foundation, Washington, DC
  • Disclosures: No financial interests/relationships or affiliations in relations to this activity.

Lindsay Shade, MHS, PA-C

  • Physician Assistant, Director of Clinical Trials and Quality, Atrium Health, Charlotte, NC
  • Disclosures: Investigator for GlaxoSmithKline, IDx, LLC., Theracos Sub, LLC., and Novartis Pharmaceuticals. She also has a relationship with Johnson and Johnson.

Byron Thomashow, MD

  • Professor of Medicine Columbia University Medical Center, Columbia University, New York, NY  
  • Disclosures: Advisory boards for AstraZeneca and GlaxoSmithKline and a consultant for Boehringer Ingelheim.

National Jewish Health
1400 Jackson St
Suite S700
Denver, CO 80206

Phone: (303) 398-1000
Toll Free: (800) 844-2305
Fax: (303) 728-6521

SUBSCRIBE

Like our programs?  Get your name added to our mailing list to know when new educational offerings are available.

14 + 1 =